Psyence Biomedical (PBM) Non-Current Assets (2023 - 2026)

Psyence Biomedical's Non-Current Assets history runs 4 years deep, the most recent figure standing at $8.5 million for Q1 2026.

• On a quarterly basis, Non-Current Assets rose 1018.48% year-over-year to $8.5 million in Q1 2026; TTM through Mar 2026 was $14.4 million, a 100.01% increase from a year earlier, with the FY2026 full-year figure at $8.5 million, up 1018.48% from the prior year.
• Non-Current Assets rose to $8.5 million in Q1 2026 per PBM's latest filing, from $5.2 million in the prior quarter.
• Across five years, Non-Current Assets topped out at $8.5 million in Q1 2026 and bottomed at -$162.5 billion in Q3 2023.
• The 4-year median for Non-Current Assets is $383111.0 (2024), against an average of -$27.1 billion.
• Across the five-year window, Non-Current Assets jumped 100.0% in 2024 and surged 51062.26% in 2025, its largest moves.
• Year by year, Non-Current Assets stood at -$162.5 billion in 2023, then jumped by 100.0% to $10126.0 in 2024, then jumped by 51062.26% to $5.2 million in 2025, then soared by 63.24% to $8.5 million in 2026.
• Per Business Quant, the three latest PBM Non-Current Assets figures stand at $8.5 million (Q1 2026), $5.2 million (Q3 2025), and $756096.0 (Q1 2025).